Small pharma tsxv
WebLONDON, March 07, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short … WebJan 25, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-duration psychedelic-assisted therapies for the treatment of mental health conditions. The Company’s current focus is on exploring new therapeutic approaches for depression. Small Pharma’s lead candidate, SPL026, is a proprietary synthetic formulation of DMT.
Small pharma tsxv
Did you know?
WebMay 3, 2024 · On April 29, 2024, Small Pharma Inc. (TSXV: DMT) (formerly Unilock Capital Corp.) completed its acquisition of Small Pharma Ltd (“Small Pharma”), a U.K.-based … WebSmall Pharma Pharmaceutical Manufacturing Short-duration psychedelics with therapy for under-served mental health conditions TSXV:DMT OTCQB: DMTTF Follow View all 32 …
WebApr 29, 2024 · VANCOUVER, British Columbia, April 29, 2024 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (formerly Unilock Capital Corp.) (the “ Company ”), announces that it has completed its previously announced acquisition of all of the outstanding shares of Small Pharma Ltd (“ Small Pharma ”), a neuropharmaceutical company specialised in IP … WebMay 5, 2024 · Ayahuasca (pronounced ‘eye-ah-WAH-ska’) is a plant-based psychoactive brew, used both socially and as a ceremonial spiritual medicine among the indigenous peoples of the Amazon basin. These ceremonial rites go back centuries. DMT is often associated with ayahuasca because it is the brew’s main psychoactive ingredient.
WebAug 3, 2024 · Small Pharma is a biotechnology company progressing a pipeline of short-acting psychedelics with therapy for the treatment of mental health conditions, with a current focus on depression. Small Pharma initiated a clinical program into DMT-assisted psychotherapy in February 2024. WebFeb 7, 2024 · Small Pharma (TSXV:DMT) earnings and revenue forecasts, price targets, future return on equity. Compare Small Pharma Inc.'s growth forecast against it's industry peers. Home Markets Discover Watchlist Portfolios Screener. Small Pharma Inc. TSXV:DMT Stock Report. Mkt Cap: CA$25.7m. Add to watchlist.
WebApr 15, 2024 · International Biotechnology Trust PLC cut its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Rating) by 25.6% during the 4th quarter, according to its most recent disclosure with the SEC.The institutional investor owned 43,656 shares of the biotechnology company's stock after selling 15,000 shares during the period.
WebMar 10, 2024 · Small Pharma is a neuroscience company specialized in discovering and developing novel treatments for mental health conditions, with a current focus on depression. Small Pharma initiated a... dhrm org chartWebMay 4, 2024 · VANCOUVER, British Columbia, May 04, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. (formerly Unilock Capital Corp.) (TSXV: DMT) (the “Company” or “Small Pharma”) is pleased to announce that the common shares in the capital of the Company (the “Common Shares”) will commence trading on the TSX Venture Exchange (the “TSXV”) … dhrm pay outWebFeb 22, 2024 · Small Pharma is a neuroscience company specialized in discovering and developing novel treatments for mental health conditions, with a focus on depression. Small Pharma initiated a clinical... cincinnati aronoff center ticketsWebFeb 15, 2024 · LONDON, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today confirms that the first subject has been dosed in a Phase I study evaluating SPL028, its … dhrm pay holiday scheduleWebOverview. Small Pharma Inc is a neuropharmaceutical company. It is committed towards the development of effective therapeutic treatments for mental health disorders. Small … cincinnati aronoff seating chartWebMar 7, 2024 · LONDON, March 07, 2024 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company ” or “ Small Pharma ”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces further positive results from the Company’s Phase IIa trial of SPL026, the first … dhrm performance evaluationWebAug 3, 2024 · Small Pharma is advancing a pipeline of DMT-based therapies and is leading the most advanced clinical trial in commercial development for DMT-assisted … cincinnati area things to do